Breast cancer cell-derived adrenomedullin (ADM) enhances the expression of UCP1 in adipocytes and promotes the phosphorylation of hormone-sensitive lipase (HSL), thereby stimulating lipolysis and the browning of adipocytes. Here, LIPE is linked to breast carcinoma.